In this study, we developed unique AI-powered algorithms to retrospectively evaluate PD-L1 expression on tumor cells (TCs) across multiple tumor types, including samples from patients with non-small cell lung cancer (NSCLC), squamous cell carcinoma of the head and neck (SCCHN), MEL, and UC. Here, CD274 is linked to neoplasm.